Marshall Wace North America’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Marshall Wace North America’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-41,366	Closed	-$501K	–	1905
2021 Q1	$501K	Buy	+41,366	New	+$820K	﹤0.01%	1198

Other funds holding LHDX

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JCM

JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Marshall Wace North America's LHDX Position: Q2 2021 in Review

Marshall Wace North America sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2021, closing a stake of 41,366 shares — an estimated $501K sold.

Marshall Wace North America first reported a position in LHDX in Q1 2021 and held it in 1 quarter. The position peaked at $501K in Q1 2021. 44 funds tracked by Wall St. Rank hold LHDX as of Q2 2021.

Marshall Wace North America reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Marshall Wace North America sold 41,366 Lucira Health, Inc. Common Stock shares in Q2 2021, an estimated $501K.
Marshall Wace North America first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Marshall Wace North America's Lucira Health, Inc. Common Stock position peaked at $501K in Q1 2021.
44 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.